A Randomized Phase 2 Study of Neratinib With or Without Fulvestrant for Patients With HER2-Positive, Estrogen Receptor-Positive Metastatic Breast Cancer
DOI: 10.1016/j.clbc.2025.05.009
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1526820925001338
其他信息:
出版社: Elsevier BV
作者: Stefania Morganti; Xiangying Chu; Tarah J. Ballinger; Nisha Unni; Sarah Sinclair; Robert Wesolowski; Alyssa M. Pereslete; Paulina Lange; Nabihah Tayob; Nancy U. Lin; Jose P. Leone; Ian E. Krop; Sara M. Tolaney; Heather A. Parsons